FDA Device Intelligence
Home › Precision Biologic Inc › CRYOcheck Factor VIII Deficient Plasma with VWF

CRYOcheck Factor VIII Deficient Plasma with VWF

Precision Biologic Inc · Model FDP08VWF · UDI-DI 00843876000589

GJT Prescription
1
510(k) clearances
14
Adverse events
3
Recalls
11
Facilities

Description

CRYOcheck Factor VIII Deficient Plasma with VWF is for clinical laboratory use as a deficient substrate in the quantitative determination of Factor VIII activity in 3.2% sodium citrated human plasma based on the activated partial thromboplastin time (APTT) assay. It is intended to be used in identifying Factor VIII deficiency and as an aid in the management of hemophilia A in individuals aged 2 years and older. For in vitro diagnostic use. CRYOcheck Factor VIII Deficient Plasma with VWF is normal human citrated plasma which has been immunodepleted of factor VIII and which contains normal levels of von Willebrand Factor (VWF), buffered with HEPES. Factor VIII has been assayed at less than 1% of normal antigen and activity levels while VWF antigen and activity levels are >50%. Device is provided frozen as 25 vials of 1.0 mL

Recalls

DateFirmReason
2015-05-11Siemens Healthcare Diagnostics, Inc.Discrepancies for Siemens BCS / BCS XP with dilution studies; erroneously high Factor IX results at the lower end of the measuring range.
2013-01-28Diagnostica Stago, Inc.Diagnostica Stago has confirmed that sometimes the delta OD measured can be changed leading to a lowered percentage result.
2005-07-08Dade Behring , Inc.sample may exhibit falsely high results

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.